Shuttle Pharmaceuticals Holdings, Inc. (SHPH) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 633.34K | 289.07K | 0 | 0 | 0 | 1.8K | 0 | 0 | 0 | 1.98K | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -633.34K | -289.07K | 0 | 0 | 0 | -1.8K | 0 | 0 | 0 | -1.98K | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | -15995.21% | - | - | - | 9.43% | - | - | - | - | - | - |
| Operating Expenses | 1.58M | 2.5M | 2.27M | 3.91M | 2.95M | 1.78M | 3.05M | 1.48M | 1.38M | 1.28M | 1.6M | 1.47M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.16M | 2.28M | 1.32M | 2.88M | 1.38M | 788.92K | 1.65M | 836.91K | 798.74K | 848.24K | 553.97K | 625.97K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 267.24K | 511.88K | 943.48K | 1.03M | 1.57M | 986.41K | 1.4M | 645.72K | 586.1K | 432.61K | 1.05M | 839.66K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 155.69K | -289.07K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.22M | -2.79M | -2.27M | -3.91M | -2.95M | -1.78M | -3.05M | -1.48M | -1.38M | -1.28M | -1.6M | -1.47M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 24.89% | -56.9% | 25.71% | -163.75% | -113.11% | -38.53% | -90.82% | -1.16% | 10.35% | -73.17% | -94.67% | -314.46% |
| EBITDA | -1.58M | -2.5M | -2.27M | -3.91M | -2.95M | -1.78M | -3.05M | -1.48M | -1.38M | -1.28M | -1.6M | -1.46M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 46.33% | -40.77% | 25.73% | -163.92% | -113.33% | -38.61% | -91% | -1.2% | 10.39% | -73.25% | -94.82% | -315.74% |
| D&A (Non-Cash Add-back) | 633.34K | 289.07K | 1.01K | 15 | 1.01K | 1.8K | 793 | 962 | 1.91K | 1.98K | 1.86K | 1.48K |
| EBIT | -2.14M | -2.6M | -2.33M | -3.68M | -3.04M | -1.44M | -3.51M | -1.6M | -1.23M | -1.11M | -1.17M | -1.45M |
| Net Interest Income | -11.91K | -17.73K | -18.42K | -21.66K | -11.93K | -159.28K | -270.15K | -416.53K | -476.06K | -509.65K | -602.7K | -712.67K |
| Interest Income | 209 | 523 | 486 | 81 | 0 | 3 | 2.52K | 14.16K | 21.45K | 22.4K | 20.77K | 19.27K |
| Interest Expense | 12.12K | 18.25K | 18.9K | 21.74K | 11.93K | 159.28K | 272.68K | 430.69K | 497.51K | 532.05K | 623.47K | 731.94K |
| Other Income/Expense | 64.35K | 173.34K | -80.36K | 203.94K | -101.77K | 178.66K | -732.52K | -548.58K | -346.18K | -357.68K | -193.61K | -718.74K |
| Pretax Income | -2.15M | -2.61M | -2.35M | -3.71M | -3.05M | -1.6M | -3.78M | -2.03M | -1.73M | -1.64M | -1.79M | -2.18M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.15M | -2.61M | -2.35M | -3.71M | -3.05M | -1.6M | -3.78M | -2.03M | -1.73M | -1.64M | -1.79M | -2.18M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 29.5% | -63.59% | 37.97% | -82.48% | -76.37% | 2.56% | -111.08% | 7.01% | -77.52% | -118.47% | -76.12% | -265.72% |
| Net Income (Continuing) | -2.15M | -2.61M | -2.35M | -3.71M | -3.05M | -1.6M | -3.78M | -2.03M | -1.73M | -1.64M | -1.79M | -2.18M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -4.30 | -12.90 | -10.50 | -32.90 | -7.50 | -5.50 | -3.70 | -2.00 | -1.00 | -1.00 | -1.10 | -1.50 |
| EPS Growth % | 42.67% | -134.55% | -183.78% | -1545% | -650% | -450% | -236.36% | -33.33% | -576.19% | -65.56% | -10% | -136.97% |
| EPS (Basic) | -4.30 | -12.90 | -10.50 | -32.90 | -7.50 | -5.40 | -3.70 | -2.00 | -1.00 | -1.00 | -1.10 | -1.50 |
| Diluted Shares Outstanding | 503.16K | 202.36K | 223.37K | 112.61K | 407.66K | 407.66K | 1.03M | 1.03M | 1.66M | 1.61M | 1.57M | 1.43M |
| Basic Shares Outstanding | 503.16K | 202.36K | 223.37K | 112.61K | 407.66K | 407.66K | 1.03M | 1.03M | 1.66M | 1.61M | 1.57M | 1.43M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |